Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 2, 2011, Pages 185-195

  Solling C ^a,b   Christensen, A T ^a,b   Krag, S ^a   Frokler J ^a,b   Wogensen, L ^a,b   Krog, J ^a,b   Tonnesen E K ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; ISCHEMIA; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY DYSFUNCTION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL ARTERY; REPERFUSION; REPERFUSION INJURY; SWINE;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CASPASE 3; CYTOKINES; ERYTHROPOIETIN; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION TESTS; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RENAL CIRCULATION; REPERFUSION INJURY; SWINE;

EID: 78651478034     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2010.02369.x     Document Type: Article

References (31)

1. Lameire N, Van BW, Vanholder R., Acute renal failure. Lancet 2005; 365: 417-30.
2. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C., Acute renal failure in critically ill patients: a multinational, multicenter study. J Am Med Assoc 2005; 294: 813-8. (Pubitemid 41175724)
3. Jang HR, Ko GJ, Wasowska BA, Rabb H., The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med 2009; 87: 859-64.
4. Coleman T, Brines M., Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care 2004; 8: 337-41.
5. Wagner F, Baumgart K, Simkova V, Georgieff M, Radermacher P, Calzia E., Year in review 2007: Critical Care-shock. Crit Care 2008; 12: 227.
6. Joyeux-Faure M., Cellular protection by erythropoietin: new therapeutic implications? J Pharmacol Exp Ther 2007; 323: 759-62.
7. Farrell F, Lee A., The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 2004; 9 (Suppl. 5): 18-30.
8. Jelkmann W, Wagner K., Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 2004; 83: 673-86.
9. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM., Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-24. (Pubitemid 39031350)
10. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW., Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-55.
11. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, Sun BK, Kim YS, Kim J, Chang YS, Bang BK., Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754-5.
12. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C., Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 2005; 75: 1100-5.
13. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D., Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006; 21: 330-6.
14. Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, Thiemermann C., Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-9.
15. Kiris I, Kapan S, Kilbas A, Yilmaz N, Altuntas I, Karahan N, Okutan H., The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. J Surg Res 2008; 149: 206-13.
16. Forman CJ, Johnson DW, Nicol DL., Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU Int 2007; 99: 162-5.
17. Simon F, Scheuerle A, Calzia E, Bassi G, Oter S, Duy CN, Kick J, Bruckner UB, Radermacher P, Schelzig H., Erythropoietin during porcine aortic balloon occlusion-induced ischemia/reperfusion injury. Crit Care Med 2008; 36: 2143-50.
18. Phillips CK, Hruby GW, Mirabile G, Motamedinia P, Lehman DS, Okhunov Z, Singh H, Schwartz M, Benson MC, Landman J., Erythropoietin-induced optimization of renal function after warm ischemia. J Endourol 2009; 23: 359-65.
19. Fenger-Eriksen C, Hartig RC, Kappel JT, Nker-Moller E, Heslop J, Frokiaer J, Tonnesen E., Renal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005; 49: 969-74.
20. Brix-Christensen V, Gjedsted J, Andersen SK, Vestergaard C, Nielsen J, Rix T, Nyboe R, Andersen NT, Larsson A, Schmitz O, Tonnesen E., Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs. Acta Anaesthesiol Scand 2005; 49: 991-8.
21. Sharples EJ, Yaqoob MM., Erythropoietin and acute renal failure. Semin Nephrol 2006; 26: 325-31.
22. Donnahoo KK, Shames BD, Harken AH, Meldrum DR., Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 1999; 162: 196-203.
23. Yazihan N, Ataoglu H, Kavas GO, Akyurek N, Yener B, Aydm C., The effect of K-ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury. J Invest Surg 2008; 21: 340-7.
24. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR., Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999; 277: 922-9.
25. Feitoza CQ, Semedo P, Goncalves GM, Cenedeze MA, Pinheiro HS, Santos OF, Landgraf RG, Pacheco-Silva A, Camara NO., Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury. Inflamm Res 2009; 59: 167-75.
26. van Wijk SJ, Hageman GJ., Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion. Free Radic Biol Med 2005; 39: 81-90.
27. Kim GT, Chun YS, Park JW, Kim MS., Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun 2003; 309: 619-24.
28. Weld KJ, Montiglio C, Bush AC, Dixon PS, Schwertner HA, Hensley DM, Cowart JR, Cespedes RD., Predicting irreparable renal ischemic injury using a real-time marker in the porcine model. J Urol 2008; 180: 2218-25.
29. Orvieto MA, Tolhurst SR, Chuang MS, Lyon MB, Ritch CR, Rapp DE, Shalhav AL., Defining maximal renal tolerance to warm ischemia in porcine laparoscopic and open surgery model. Urology 2005; 66: 1111-5.
30. Toma C, Letts DP, Tanabe M, Gorcsan J III, Counihan PJ., Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion. J Mol Cell Cardiol 2007; 43: 130-6.
31. Brines M, Patel NS, Villa P, Brines C, Mennini T, De PM, Erbayraktar Z, Erbayraktar S, Sepodes B, Thiemermann C, Ghezzi P, Yamin M, Hand CC, Xie QW, Coleman T, Cerami A., Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA 2008; 105: 10925-30.